Multiple logistic regression analysis with cardiovascular mortality as a dependent variable and the metabolic syndrome* or its components as independent variables
| . | All subjects (209 deaths) . | Diabetic patients (168 deaths) . | ||
|---|---|---|---|---|
| RR (95% CI) . | P . | RR (95% CI) . | P . | |
| The metabolic syndrome* | 1.81 (1.24–2.65) | 0.002 | 1.15 (0.68–1.94) | 0.60 |
| Obesity | 1.10 (0.63–1.96) | 0.76 | 0.87 (0.43–1.76) | 0.70 |
| Dyslipidemia | 0.99 (0.63–1.58) | 0.98 | 0.93 (0.54–1.61) | 0.80 |
| Hypertension | 1.78 (1.09–2.91) | 0.02 | 1.43 (0.76–2.68) | 0.27 |
| Microalbuminuria | 2.80 (1.62–4.83) | <0.001 | 3.17 (1.70–5.91) | <0.001 |
| Insulin resistance† | 1.53 (0.88–2.64) | 0.13 | 1.44 (0.56–3.71) | 0.45 |
| . | All subjects (209 deaths) . | Diabetic patients (168 deaths) . | ||
|---|---|---|---|---|
| RR (95% CI) . | P . | RR (95% CI) . | P . | |
| The metabolic syndrome* | 1.81 (1.24–2.65) | 0.002 | 1.15 (0.68–1.94) | 0.60 |
| Obesity | 1.10 (0.63–1.96) | 0.76 | 0.87 (0.43–1.76) | 0.70 |
| Dyslipidemia | 0.99 (0.63–1.58) | 0.98 | 0.93 (0.54–1.61) | 0.80 |
| Hypertension | 1.78 (1.09–2.91) | 0.02 | 1.43 (0.76–2.68) | 0.27 |
| Microalbuminuria | 2.80 (1.62–4.83) | <0.001 | 3.17 (1.70–5.91) | <0.001 |
| Insulin resistance† | 1.53 (0.88–2.64) | 0.13 | 1.44 (0.56–3.71) | 0.45 |
Adjusted for age, sex, LDL cholesterol, and current smoking.
The metabolic syndrome was defined based on the recent WHO proposal (17);
defined as highest quartile of HOMAIR.